Login to Your Account

It’s a rocky start for the biotech sector so far in May

By Peter Winter

Monday, May 12, 2014

With first quarter earnings season in full swing investors have not been overly impressed with what biotech companies are reporting. As a result, the overall sector’s performance on the capital markets has dipped so far this month. There have been a number of stocks that beat earnings estimates but were still hit by selling.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription